Anticonvulsants, folic acid, and epilepsy.
D000748:Anemia, Macrocytic / Q000139:chemically induced / Q000188:drug therapy; D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001812:Blood-Brain Barrier / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004828:Epilepsies, Partial; D004827:Epilepsy / Q000097:blood; D005492:Folic Acid / Q000097:blood / Q000134:cerebrospinal fluid / Q000378:metabolism / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000494:pharmacology; D051379:Mice; D010634:Phenobarbital / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D011324:Primidone / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D012640:Seizures / Q000139:chemically induced
D000927:Anticonvulsants; D011324:Primidone; D010672:Phenytoin; D005492:Folic Acid; D002955:Leucovorin; D010634:Phenobarbital